As the association between blood NfL levels and secondary neurodegeneration remained after adjustment for age, sex, hypertension and recurrent ischemic lesions [24], these results point to the potential utility of blood NfL levels as a biomarker of stroke-induced secondary neuroaxonal injury that is independent of age. The gene discussed is NEFL; the disease is Hypertension.